43 Publications (Page 1 of 2)
2026
Design and Development of a Novel LXRβ/PPARδ Dual Agonist for Memory Impairment and Pathology in 3xTg-AD Animal Model of Alzheimer’s Disease. ACS Chemical Biology
. | Journal Article
In Vitro Data - HEPG2 Cells. figshare
In Vitro - Other. figshare
In Vivo Data - B6 mice. figshare
Modulation of TH17 cell activity by REV–ERB agonists: path toward novel treatments for canine meningoencephalitis of unknown origin. npj Veterinary Sciences
. | Journal Article
PrimePCR Fatty Liver (Human) Validation Files from Bio-Rad
Protease-Mediated TAR DNA-Binding Protein 43 (TDP-43) Pathogenesis: From Molecular Mechanisms to Therapeutic Opportunities. ACS Pharmacology & Translational Science
. | Journal Article
RNA-seq data and files from the mouse RNA-seq studies.
2025
Cyclopropane xenolipids resemble monounsaturated fatty acids and modulate peroxisome proliferator-activated receptors. Journal of Lipid Research
. | Journal Article
2024
AHA BCVS Poster 2020. figshare
AHA Scientific Sessions Poster 2019. figshare
Cholesterol Quantification for C57Bl/6J mice
Notes and raw data. figshare
Notes and raw data. figshare
REV-ERB activation as a novel pharmacological approach for treating inflammatory pain
REV-ERB activation as a novel pharmacological approach for treating inflammatory pain. figshare
2023
Data from Fructose Promotes Cytoprotection in Melanoma Tumors and Resistance to Immunotherapy
Data from Fructose Promotes Cytoprotection in Melanoma Tumors and Resistance to Immunotherapy
REV-ERB activation as a novel pharmacological approach for treating inflammatory pain.Makhija, Sangeet⋅Griffett, Joshua D⋅Veerakanellore, Giri Babu⋅Burris, Thomas P⋅Elgendy, Bahaa and Griffett, KristineFrontiers in pharmacology, vol. 14, pp. 1171931, 2023.
| Journal Article
Supplemental Figures S1-S9 from Fructose Promotes Cytoprotection in Melanoma Tumors and Resistance to Immunotherapy
Supplemental Figures S1-S9 from Fructose Promotes Cytoprotection in Melanoma Tumors and Resistance to Immunotherapy
2022
Antihyperlipidemic Activity of Gut-Restricted LXR Inverse AgonistsGriffett, Kristine⋅Hayes, Matthew⋅Bedia-Diaz, Gonzalo⋅Appourchaux, Kevin⋅Sanders, Ryan⋅Boeckman, Michael P.⋅Koelblen, Thomas⋅Zhang, Jinsong⋅Schulman, Ira G.⋅Elgendy, Bahaa and Burris, Thomas P.ACS Chemical Biology.
| Journal Article